Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Bonnet (Québec, Canada), K. Habbout (Québec, Canada), J. Omura (Québec, Canada), R. Paulin (Québec, Canada), S. Provencher (Québec, Canada), O. Boucherat (Québec, Canada). Implication of Enhancer of Zeste Homolog 2 in Pulmonary Arterial Hypertension. 5053

Member's Comments

No comment yet.

Related content which might interest you: Role of CHK1 in Pulmonary Arterial Hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Right Ventricular Failure in an Animal Model of Severe Pulmonary Arterial Hypertension: eNOS Uncoupling and Protein Kinase G Signaling in the Transition from Adaptive to Maladaptive Remodeling Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Multi-Omics Analysis of the PDGF Response in Pulmonary Vascular Smooth Muscle Cells from Patients with Pulmonary Arterial Hypertension: Implication of the NMDAR Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Contribution of BMP9 to Pulmonary Arterial Hypertension Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension Year: 2017 Role of class IIa histone deacetylases in the pathogenesis of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Late Breaking Abstract - Chronic Hypoxia Promotes Pulmonary Venous Smooth Muscle Cells Proliferation by Upregulating Calcium Sensing Receptor Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 LSC - 2017 - Proteasomal Activator 200 (PA200) Regulates Cellular Proliferation: A Putative Role For IPF And Lung Cancer Pathogenesis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Long Non-coding RNA H19 in Right Ventricular Failure associated with Pulmonary Arterial Hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Gene-Gene Interaction between EPAS1 and EGLN1 in Patients with High-Altitude Pulmonary Edema Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Effects of Long Term Exogenous Apelin Application in Experimental Pulmonary Hypertension Model Created with Monocrotaline Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Liquid biopsy for Chronic Thromboembolic Pulmonary Hypertension: Circulating microRNA profile by Next Generation Sequencing Source: International Congress 2017 – PAH and CTEPH Year: 2017 A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018